OLIG2 immunolabeling in feline ependymoma

Area of Science:

• Veterinary Pathology
• Neuro-oncology
• Immunohistochemistry

Background:

• Ependymoma is a common feline glioma, often found in the lateral and third ventricles, with varied histological patterns.
• Oligodendrocyte transcription factor (OLIG2) is typically minimal in ependymomas but is a common marker for other gliomas.

Purpose of the Study:

• To characterize the immunolabeling pattern of OLIG2 in feline ependymoma.
• To evaluate the utility of OLIG2 as a diagnostic marker for feline ependymoma.

Main Methods:

• Immunohistochemistry was performed on 19 feline ependymoma cases.
• OLIG2 and GFAP immunolabeling patterns were analyzed.
• Histologic features, including rosettes and pseudorosettes, were examined.

Main Results:

• Nuclear OLIG2 immunolabeling was present in 17 out of 19 cases, with variable intensity and distribution.
• GFAP immunolabeling was variable and often localized in neoplastic ependymal cells, particularly in rosettes.
• OLIG2 immunolabeling was widespread in feline ependymoma, differing from findings in other species.

Conclusions:

• OLIG2 is widely expressed in feline ependymoma.
• The widespread distribution of OLIG2 in feline ependymoma contrasts with its expression in other species.
• OLIG2 should not be relied upon as a specific marker for feline oligodendroglioma.